期刊文献+

肾母细胞瘤组织中β-连环素和MMP-7的表达

Expression of β-catenin and MMP-7 in nephroblastoma and its correlation to the invasion and metastasis
下载PDF
导出
摘要 目的:探讨肾母细胞瘤组织中β-连环素(β-catenin)和基质金属蛋白酶-7(matrix metalloproteinase-7,MMP-7)的表达及与分化、浸润和转移的关系。方法:应用免疫组化SP法检测30例肾母细胞瘤组织中β-连环素和MMP-7的表达,并与对照组(6例瘤旁正常组织,9例非肿瘤切除的肾组织)相比较。结果:对照组中无β-连环素异常表达,MMP-7不表达,β-连环素和MMP-7在肾母细胞瘤组织中的阳性表达率分别为(41.22±17.06)%和(54.21±10.92)%,在不同组织学分型中差异均有统计学意义,直线相关分析显示2者存在正相关关系(P<0.05,r=0.409)。结论:β-连环素和MMP-7的表达与肾母细胞瘤的浸润和转移密切相关,可作为判断患者预后的重要临床指标。 Aim: To evaluate the expressions of β-catenin and MMP-7 in nephroblastoma and their correlation with the, differentiation,invasion and metastasis. Methods: The expressions of p-catenin and MMP-7 were studied in 30 cases of nephroblastoma by immunohistochemistry. Results: The positive expression rates of β-catenin and MMP-7 were (41. 22 ± 17. 06)% and(54. 21 ±10.92)% respectively. There were significant statistic differences between the expressions and different histologic types(P <0. 05, r =0. 409). A positive correlation was certified between p-catenin and MMP-7 by linear correlation analysis. Conclusion: The expressions of p-catenin and MMP-7 are closely related to the differentiation,invasion and metastasis. Both p-catenin and MMP-7 can be important clinical parameters for judging prognosis of nephroblastoma.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2004年第2期214-216,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关基金资助项目 324410085
关键词 肾母细胞瘤 β—连环素 基质金属蛋白酶—7 nephroblastoma B-catenin matrix metalloproteinase-7
  • 相关文献

参考文献11

  • 1Bonadio JF, Storer B, Norkool P, et al. Anaplastic Wilms'tumor:clinical and pathologic studies. J Clin Oncol, 1985,3(4) :513.
  • 2Crawford HC , Fingleton BM, Rudolph-Owen LA,et al. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene, 1999,18 ( 18 ):2 883.
  • 3Beckwith JB. National Wilms tumor study: an update for pathologists. Padiatr Dev Pathol, 1998, 1 ( 1 ) :79.
  • 4Bullions LC, Levine AJ. The role of beta-catenin in cell adhesion, signal transduction, and cancer. Curr Opin Oncol,1998,10(1) :81.
  • 5He TC,Sparks AB,Rago C,et al. Identification of c-MYC as a target of the APC pathway . Science, 1998,281 (5 382):1 509.
  • 6Tetsu O, McCormick F. Beta-catenin regulates expression of cyclinD1 in colon carcinoma cells. Nature, 1999, 398(6 726) :422.
  • 7Koesters R, Ridder R, Kopp-Schneider A,et al. Mutational Activation of the β-Catenin Proto-Oncogene Is a Common Event in the Development of Wilms ' Tumors. Cancer Res,1999,59(16): 3 880.
  • 8Maiti S, Alam R, Amos C,et al. Frequent Association of β-Catenin and WT1 Mutations in Wilms Tumors. Cancer Res,2000, 60 (22): 6 288.
  • 9Ougolkov AV, Yamashita K, Mai M,et al. Oncogenic betacatenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology, 2002, 122 ( 1 ) :60.
  • 10Mitsiades N, Yu WH, Poulaki V,et al. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res,2001, 61(2) :577.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部